Singapore markets open in 3 hours 39 minutes
Straits Times Index
3,322.08 -8.69 (-0.26%) S&P 500
5,360.79 +13.80 (+0.26%) Dow
38,868.04 +69.05 (+0.18%) Nasdaq
17,192.53 +59.40 (+0.35%) Bitcoin USD
69,568.46 -129.66 (-0.19%) CMC Crypto 200
1,443.70 -2.97 (-0.21%)
PCVX Oct 2024 80.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:37PM EDT. Market open.
| Previous close | 21.11 |
| Open | 21.10 |
| Bid | 15.80 |
| Ask | 20.00 |
| Strike | 80.00 |
| Expiry date | 2024-10-18 |
| Day's range | 21.11 - 21.11 |
| Contract range | N/A |
| Volume | |
| Open interest | 7 |
Simply Wall St.We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- GuruFocus.com
Vaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Overview
Consistent with Analyst Projections Amidst Strategic Advancements
GlobeNewswireVaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
-- VAX-31 Adult Phase 1/2 Study Enrollment Completed; Topline Safety, Tolerability and Immunogenicity Data Expected in Third Quarter of 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Readout, Vaxcyte to Advance VAX-24 or VAX-31 to Adult Phase 3 Program -- -- VAX-24 Infant Phase 2 Study Enrollment Completed; Topline Data from Primary Immunization Series Expected by End of First Quarter of 2025, Followed by Topline Data from Booster Dose by End of 2025 -- -- $1.9 Billion in Cash, Cash Equivalen
© 2024 Yahoo. All rights reserved.